← Leaderboards
David Van De Vijver
Erasmus Medical Center
$2,523,850
Attributed
$2,523,850
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $689.7K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,523,850 · 1
By mechanism
R01$2,523,850 · 1
Top collaborators
No co-investigators on record.
Most similar at Erasmus Medical Center
Same institution · by research overlap
- Charles Achim Bernard Boucher$628,572
Others in their field
Other Emerging Leaders on “Hiv-1”
- Yunda Huang · Fred Hutchinson Cancer Center$53,891,173
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$46,167,724
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Wilton B Williams · Duke University$19,801,567
- Priyamvada Acharya · Duke University$16,177,967
Research focus
Hiv-1GuidelinesHealth SystemAnti-Retroviral AgentsBrazilAcquired Drug ResistanceAdherenceClinical PracticeClinical TrialsCombined Modality TherapyComparativeCountryCaringAffectCd4 Lymphocyte CountAlgorithmsDrug ResistanceEventExperimental StudyFailureFutureGenerationsGenesIncome
Grant awards (5)
Novel mechanisms contributing to failure of dolutegravir-containing cART in clinical practice$676,315
R01 · FY2023 · AI · contact PI
Novel mechanisms contributing to failure of dolutegravir-containing cART in clinical practice$13,388
R01 · FY2023 · AI · contact PI
Novel mechanisms contributing to failure of dolutegravir-containing cART in clinical practice$606,316
R01 · FY2022 · AI · contact PI
Novel mechanisms contributing to failure of dolutegravir-containing cART in clinical practice$614,205
R01 · FY2021 · AI · contact PI
Novel mechanisms contributing to failure of dolutegravir-containing cART in clinical practice$613,626
R01 · FY2020 · AI · contact PI